Clinical and Translational Science Award

临床和转化科学奖

基本信息

  • 批准号:
    9085610
  • 负责人:
  • 金额:
    $ 42.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-18 至 2020-03-31
  • 项目状态:
    已结题

项目摘要

Academic Medical Centers have the responsibility to train the next generation of biomedical scientists and physician scientists for careers in clinical and translational research. The Physician-Scientist Workforce Group (PS-WG) identified limited diversity in the physician-scientist workforce as a concern to the NIH. In response to these charges, this Scientific Teams Advancing Research Translations (START) TL1 Program will orient medical students and graduate students into translational science and provide advanced training for MDfellows who align with CTSA goals of advancing therapeutics, clinical interventions and behavioral modifications to improve health. The START Program will leverage existing MCW Pipeline Programs to mentor highly qualified high school and undergraduates of diverse backgrounds towards careers in clinical translation research; support one-year of research training for medical, graduate, and MD-PhD students and MD-fellows in clinical and translational research towards MS or PhD degrees, and mentor START Program graduates throughout their research careers at MCW. To complete these aims, the START Program will leverage the pipeline of established high school and undergraduate Programs at MCW to mentor highly qualified young students of diversity for careers as clinical and translational scientists. The START Program will leverage the Physical Scientist Pathway (PSP), a flagship professional development program at MCW that allows medical students to work with peers and faculty to build on the foundation of medical school experiences, to pursue an area of common research interest in greater depth. The START Program will provide one year of stipend for medical students, graduate students and MD-fellows to conduct research and develop fundamental, quantitative skills involved in clinical and translational research as components of PhD and MS degree. During the year of research, students will participate in workshops that teach grant writing, manuscript writing, and professional development skills, including best practice strategies to optimize communication skills. Trainees will participate in bi-annual conferences to present their current studies in a team-based environment and use an Individual Development Plan (IDP) to optimize training experiences. Graduates of the START Program are the next generation of scientist and physician-scientist who will improve the health of our nation and community.
学术医学中心有责任培养下一代生物医学科学家, 医生科学家在临床和转化研究的职业生涯。物理学家-科学家工作组 (PS-WG)将医生-科学家劳动力的有限多样性确定为NIH关注的问题。响应于 这些费用,这个科学团队推进研究翻译(START)TL 1计划将导向 医学生和研究生进入转化科学,并为MD研究员提供高级培训 与CTSA推进治疗、临床干预和行为干预的目标保持一致, 修改以改善健康。START计划将利用现有的MCW管道计划, 指导高素质的高中生和不同背景的本科生走向临床职业 翻译研究;支持医学,研究生和MD-PhD学生为期一年的研究培训, 医学博士-临床和转化研究的研究员,硕士或博士学位,并指导START计划 毕业生在MCW的整个研究生涯。为实现这些目标,《削减战略武器条约》将 充分利用MCW现有的高中和本科课程, 合格的年轻学生的多样性的职业生涯作为临床和转化科学家。开始进程 将利用物理科学家途径(PSP),在MCW的旗舰专业发展计划, 允许医学生与同行和教师合作,建立在医学院的基础上, 经验,追求更深入的共同研究兴趣的领域。《削减战略武器条约》将 为医学生、研究生和医学博士研究员提供一年的奖学金, 发展参与临床和转化研究的基本定量技能,作为博士学位的组成部分 MS学位。在研究期间,学生将参加教授资助金写作的研讨会, 手稿写作和专业发展技能,包括最佳实践策略,以优化 沟通能力受训人员将参加一年两次的会议, 基于团队的环境并使用个人发展计划(IDP)来优化培训体验。 START计划的毕业生是下一代科学家和物理学家,他们将提高 我们国家和社区的健康。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David C Brousseau其他文献

Return visits after emergency department treatment for sickle cell pain crises
急诊科治疗镰状细胞性疼痛危象后的回访
Quality Improvement Project to Improve the Timeliness of Care for Children With Testicular Torsion in the Emergency Department
提高急诊科睾丸扭转儿童护理及时性的质量改进项目
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    1.1
  • 作者:
    Sri S. Chinta;M. Gray;Matthew Kopetsky;Shannon H. Baumer;A. Drendel;E. Roth;Catherine C Ferguson;Mark Nimmer;Kevin Boyd;David C Brousseau
  • 通讯作者:
    David C Brousseau
The anesthetic effectiveness of lidocaine-adrenaline-tetracaine gel on finger lacerations.
利多卡因-肾上腺素-丁卡因凝胶对手指撕裂伤的麻醉效果。
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    1.4
  • 作者:
    N. White;Michael K. Kim;David C Brousseau;J. Bergholte;H. Hennes
  • 通讯作者:
    H. Hennes
Acute Idiopathic Thrombocytopenic Purpura of Childhood-Diagnosis and Therapy
儿童急性特发性血小板减少性紫癜的诊断和治疗
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    1.4
  • 作者:
    Julie A. Panepinto;David C Brousseau
  • 通讯作者:
    David C Brousseau
Reported Knowledge and Management of Potential Penicillin Allergy in Children.
儿童潜在青霉素过敏的知识和管理报告。
  • DOI:
    10.1016/j.acap.2019.01.002
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    D. Vyles;R. Mistry;Viday Heffner;Patrick C. Drayna;A. Chiu;A. Visotcky;R. Fraser;David C Brousseau
  • 通讯作者:
    David C Brousseau

David C Brousseau的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David C Brousseau', 18)}}的其他基金

Sickle Cell Improvement: ENhancing Care in the Emergency Department (SCIENCE)
镰状细胞病的改善:加强急诊科的护理(科学)
  • 批准号:
    10855133
  • 财政年份:
    2021
  • 资助金额:
    $ 42.23万
  • 项目类别:
J. NRSA Training Core
J.NRSA 培训核心
  • 批准号:
    10175077
  • 财政年份:
    2015
  • 资助金额:
    $ 42.23万
  • 项目类别:
Clinical and Translational Science Award
临床和转化科学奖
  • 批准号:
    9274055
  • 财政年份:
    2015
  • 资助金额:
    $ 42.23万
  • 项目类别:
Clinical and Translational Science Award
临床和转化科学奖
  • 批准号:
    9128784
  • 财政年份:
    2015
  • 资助金额:
    $ 42.23万
  • 项目类别:
The Delaware Comprehensive Sickle Cell Research Center
特拉华州综合镰状细胞研究中心
  • 批准号:
    10463769
  • 财政年份:
    2014
  • 资助金额:
    $ 42.23万
  • 项目类别:
The Delaware Comprehensive Sickle Cell Research Center
特拉华州综合镰状细胞研究中心
  • 批准号:
    10664915
  • 财政年份:
    2014
  • 资助金额:
    $ 42.23万
  • 项目类别:
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
静脉注射镁治疗镰状细胞血管闭塞危机
  • 批准号:
    8528213
  • 财政年份:
    2010
  • 资助金额:
    $ 42.23万
  • 项目类别:
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
静脉注射镁治疗镰状细胞血管闭塞危机
  • 批准号:
    7758174
  • 财政年份:
    2010
  • 资助金额:
    $ 42.23万
  • 项目类别:
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
静脉注射镁治疗镰状细胞血管闭塞危机
  • 批准号:
    8059606
  • 财政年份:
    2010
  • 资助金额:
    $ 42.23万
  • 项目类别:
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
静脉注射镁治疗镰状细胞血管闭塞危机
  • 批准号:
    8225224
  • 财政年份:
    2010
  • 资助金额:
    $ 42.23万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 42.23万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 42.23万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.23万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了